Literature DB >> 9282514

Status of Plasmodium falciparum resistance to chloroquine in Orissa.

S K Satpathy1, R C Jena, R S Sharma, R C Sharma.   

Abstract

Orissa is known for its contribution of 15-20% of malaria cases to the national total. Deaths due to malaria in the state are also not uncommon. Proportion of P. falciparum cases have reached to 85%. In the recent years over 0.3 million confirmed malaria cases have been reported each year. Annual consumption of chloroquine in the state is over 170 lakh tablets. A 17 year study on monitoring of choloroquine resistance in P. falciparum in Orissa revealed that out of a total of 1165 tests conducted in vivo, in 12% of the cases RI level of resistance was detected. And 4.4% cases were of RII and 1.9% RIII level. 51% of the sample tested in vitro showed P. falciparum resistance to chloroquine. P. falciparum resistance to chloroquine appears to have been developed by the parasite over the length and breadth of the state. Strengthening of the monitoring of drug resistance in P. falciparum in the state is indicated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9282514

Source DB:  PubMed          Journal:  J Commun Dis        ISSN: 0019-5138


  3 in total

Review 1.  Combination therapy for malaria: the way forward?

Authors:  François Nosten; Philippe Brasseur
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Progressive increase in point mutations associates chloroquine resistance: Even after withdrawal of chloroquine use in India.

Authors:  Sabyasachi Das; Satyajit Tripathy; Sourav Chattopadhayay; Balaram Das; Santanu Kar Mahapatra; Amiya Kumar Hati; Somenath Roy
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-06-29       Impact factor: 4.077

3.  A clinical and molecular study of artesunate + sulphadoxine-pyrimethamine in three districts of central and eastern India.

Authors:  Prakriti Srivastava; Jagnyeswar Ratha; Naman K Shah; Neelima Mishra; Anupkumar R Anvikar; Surya K Sharma; Manoj K Das; Bina Srivastava; Neena Valecha
Journal:  Malar J       Date:  2013-07-17       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.